Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

WEIGHT loss jabs could raise the risk of sudden blindness, a study warns. Injections like Wegovy, Mounjaro and Ozempic are ...

The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, ...

More than 60 billion euros (£52 billion) has been wiped off the stock market value of Ozempic and Wegovy weight loss drug ...

Whenever you successfully shed excess weight and arrive at a leaner and healthier version of yourself, the prime concern ...

If you’ve spent any time in the real world lately, chances are you’ve heard of Ozempic, Wegovy, Mounjaro or semaglutide.

Though GLP-1 drugs drive major weight loss, researchers warn they may fall short in improving heart and lung fitness.

ENDO 2025 Tirzepatide Outperforms Semaglutide on Combined T2D Goals Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.